Terminal cancer patients could be helped by a new drug that stops growth of the disease, a new study has found.
Some cancers don't respond to immunotherapy - a treatment that uses the immune system to fight the disease - but a new treatment may reverse the resistance.
The innovative two-prong treatment uses immunotherapy in combination with an experimental drug called guadecitabine, The Guardian reports. It could offer a new option for patients with lung cancer and other tumours whose cancer has progressed and resisted immunotherapy.
